Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,401–1,500 of 2,883
Ghosh, I., Liu, C. S., Swardfager, W., Lanctôt, K. L., & Anderson, N. D. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103683 · Cited by 21
Dungan, C. M., Wells, J. M., & Murach, K. A. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00553.2022 · Cited by 21
Intersection of Inflammation and Senescence in the Aging Lung Stem Cell Niche
Allen, N. C., Reyes, N. S., Lee, J. Y., & Peng, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932723 · Cited by 26
Senescence and fibrosis in salivary gland aging and disease
Nelson, D. A., Kazanjian, I., Melendez, J. A., & Larsen, M. (2024) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2024.02.009 · Cited by 29
“76 Murine models that harnessed the activity of p16 INK4A to abate senescence were shown to limit age-related declines in cognitive, adipose, cardiac, and renal function, 77 demonstrating the benefit of senescence abatement to age-related loss of organ function.”
BackgroundLee, H. G., Roh, S., Kim, H. J., Kim, S., Hong, Y., Lee, G., & Jeon, O. H. (2022) · Nanoscale Horizons · doi:10.1039/d2nh00220e · Cited by 22
Sharma, R. (2021) · PharmaNutrition · doi:10.1016/j.phanu.2021.100281 · Cited by 23
Meiners, F., Hinz, B., Boeckmann, L., Secci, R., Sueto, S. O. B., Kuepfer, L., Fuellen, G., & Barrantes, I. (2024) · Scientific Reports · doi:10.1038/s41598-024-55870-4 · Cited by 22
Cellular and molecular features of senescence in acute lung injury
Huidobro, C., Martín-Vicente, P., López‐Martínez, C., López-Alonso, I., Amado‐Rodríguez, L., Crespo, I., & Albaiceta, G. M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111410 · Cited by 20
Wong, A., Kieu, T., & Robbins, P. D. (2020) · Aging · doi:10.18632/aging.202321 · Cited by 20
Immunosenescence: A new direction in anti-aging research
Li, H., Lin, S., Wang, Y., Shi, Y., Fang, X., Wang, J., Cui, H., Bian, Y., & Qi, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112900 · Cited by 23
Complement C3 deficiency ameliorates aging related changes in the kidney
Wu, X., Lin, L., Cui, J., Chen, Y., Yang, L., & Wan, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118370 · Cited by 23
He, J., Li, J., Li, Y., Xu, Z., Ma, M., Chen, H., Chen, P., Lv, L., Shang, X., & Liu, G. (2024) · Aging · doi:10.18632/aging.205538 · Cited by 22
The impact of autophagy on the development of senescence in primary tubular epithelial cells
Baisantry, A., Bhayana, S., Wrede, C., Hegermann, J., Haller, H. G., Melk, A., & Schmitt, R. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1234547 · Cited by 22
Levandowski, C. B., Jones, T., Gruca, M. A., Ramamoorthy, S., Dowell, R. D., & Taatjes, D. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001364 · Cited by 19
Urothelial Senescence in the Pathophysiology of Diabetic Bladder Dysfunction—A Novel Hypothesis
Klee, N., McCarthy, C. G., Lewis, S., McKenzie, J., Vincent, J., & Webb, R. C. (2018) · Frontiers in Surgery · doi:10.3389/fsurg.2018.00072 · Cited by 25
Matsuyama, S., Palmer, J., Bates, A., Poventud‐Fuentes, I., Wong, K. A., Ngo, J., & Matsuyama, M. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654587 · Cited by 24
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer
Mourkioti, I., Polyzou, A., Veroutis, D., Theocharous, G., Lаgopati, N., Gentile, E., Stravokefalou, V., Thanos, D.-F., Havaki, S., Kletsas, D., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02769-z · Cited by 23
Thompson, E. L., Hu, J., & Niedernhofer, L. J. (2021) · Cancers · doi:10.3390/cancers13092241 · Cited by 20
Long-lived post-mitotic cell aging: is a telomere clock at play?
Burbano, M. S. J., & Gilson, É. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111256 · Cited by 22
Capillaries as a Therapeutic Target for Heart Failure
Yoshida, Y., Shimizu, I., & Minamino, T. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17064 · Cited by 22
Aging Lung: Molecular Drivers and Impact on Respiratory Diseases—A Narrative Clinical Review
Górski, P., Białas, A. J., & Piotrowski, W. J. (2024) · Antioxidants · doi:10.3390/antiox13121480 · Cited by 32
Sumoylation in Cellular Senescence and Aging
Gong, L., Sun, Q., & Li, D. (2017) · Current Molecular Medicine · doi:10.2174/1566524016666161223104915 · Cited by 19
Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges
Li, D., Li, Y., Ding, H., Wang, Y., Xie, Y., & Zhang, X. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100439 · Cited by 22
“Different cell types make up the intricate structure of the heart, including cardiomyocytes, endothelial cells, fibroblasts, vascular smooth muscle cells (VSMCs), immune cells, and cardiac progenitor cells (CPCSs) [75].”
BackgroundSenescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues
Rolas, L., Stein, M., Barkaway, A., Reglero-Real, N., Sciacca, E., Yaseen, M., Wang, H., Vázquez-Martínez, L., Golding, M., Blacksell, I. A., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00182-x · Cited by 26
“In this context, the use of senescence-ablator transgene mouse models (Baker et al, 2016; Baker et al, 2011; Grosse et al, 2020), senolytic therapies (Camell et al, 2021; Hickson et al, 2019; Justice et al, 2019; Suda et al, 2021; Xu et al, 2018), and senescent reporter mice (Grosse et al, 2020),…”
Bartolomucci, A., Kane, A. E., Gaydosh, L. M., Razzoli, M., McCoy, B. M., Ehninger, D., Chen, B. H., Howlett, S. E., & Snyder‐Mackler, N. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae135 · Cited by 25
New Trends in Aging Drug Discovery
Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., López-Rodríguez, M. L., & Ortega‐Gutiérrez, S. (2022) · Biomedicines · doi:10.3390/biomedicines10082006 · Cited by 22
“Importantly, preclinical studies in genetically modified aged mouse models have demonstrated that clearance of SnCs from cardiovascular organs reverses cardiac fibrosis and hypertrophy [9,49].”
BackgroundJi, W., Zhou, H., Liang, W., Zhang, W., Gong, B., Yin, T., Chu, J., Zhuang, J., Zhang, J., Luo, Y., et al. (2024) · Small · doi:10.1002/smll.202308574 · Cited by 29
Minami, S., Yamamoto, T., Yamamoto‐Imoto, H., Isaka, Y., & Hamasaki, M. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.02.005 · Cited by 26
Gong, X., Shen, H., Guo, L., Huang, C., Su, T., Wang, H., Feng, S., Yang, S., Huo, F., Liu, H., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00337-9 · Cited by 21
Wen, Z., Xia, G., Liang, C., Wang, X., Huang, J., Zhang, L., Shan, D., Song, W. C., & Cao, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0141 · Cited by 26
The romantic history of signaling pathway discovery in cell death: an updated review
Wang, L., Liu, X., Li, Q.-Q., Zhu, Y., Ren, H.-L., Song, J., Zeng, J., Mei, J., Tian, H., Rong, D., et al. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04873-2 · Cited by 24
Combining stem cell rejuvenation and senescence targeting to synergistically extend lifespan
Kaur, P., Otgonbaatar, A., Ramamoorthy, A., Chua, E. H. Z., Harmston, N., Gruber, J., & Tolwinski, N. S. (2022) · Aging · doi:10.18632/aging.204347 · Cited by 22
Hughes, B. K., Wallis, R., & Bishop, C. L. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03768-4 · Cited by 19
Samad, N., Hafeez, F., & Imran, I. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16048-x · Cited by 24
Sharma, R., & Bala, E. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100579 · Cited by 21
Zhao, Y., Zhu, X., Ma, W., Zhang, Y., Yuan, F., Kim, S. R., Tang, H., Jordan, K. L., Lerman, A., Tchkonia, T., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07666-1 · Cited by 24
“Two weeks later, RAS mice were randomly assigned to 3.3mg/kg AP20187 (B/B homodimerizer, Clontech, Mountain View, CA) or vehicle injections 3 times a week [15] ( n = 6 each).”
Promoting Articular Cartilage Regeneration through Microenvironmental Regulation
Liu, K., Zhang, B., & Zhang, X. (2024) · Journal of Immunology Research · doi:10.1155/2024/4751168 · Cited by 25
“Chondrocytes with high expression of p16 tend to secrete more ECM catabolic factors, destroying the cartilage [132], an essential factor affecting the microenvironment of articular cartilage.”
BackgroundEndothelial toll‐like receptor 4 maintains lung integrity via epigenetic suppression of p16INK4a
Kim, S., Shan, P., Hwangbo, C., Zhang, Y., Min, J., Zhang, X., Ardito, T. A., Li, A., Peng, T., Sauler, M., et al. (2019) · Aging Cell · doi:10.1111/acel.12914 · Cited by 18
Nassir, C. M. N. C. M., Damodaran, T. K., Yusof, S. R., Norazit, A., Chilla, G. S. V. N., Huen, I., Nagaraja, B. P. K., Ibrahim, N. M., & Mustapha, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081207 · Cited by 25
Sorokina, A. G., Orlova, Y. A., Grigorieva, O., Novoseletskaya, E. S., Basalova, N. A., Alexandrushkina, N. A., Vigovskiy, M. A., Kirillova, K. I., Balatsky, A. V., Samokhodskaya, L. M., et al. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112176 · Cited by 26
Research on Werner Syndrome: Trends from Past to Present and Future Prospects
Tsuge, K., & Shimamoto, A. (2022) · Genes · doi:10.3390/genes13101802 · Cited by 23
Boe, D. M., Hulsebus, H. J., Najarro, K. M., Mullen, J. E., Kim, H., Tan, A. C., McMahan, R. H., & Kovacs, E. J. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi0620-399rr · Cited by 20
Koppula, S., Akther, M., Haque, M. E., & Kopalli, S. R. (2021) · Nutrients · doi:10.3390/nu13114058 · Cited by 20
Zhang, Y., Zhang, Q., Chu, Z., Chen, L., Chen, J., Yang, Y., Tang, H., Cheng, G., Ma, A., Zhang, Y., et al. (2022) · Chemical Communications · doi:10.1039/d2cc05278d · Cited by 19
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Defining and characterizing neuronal senescence, ‘neurescence’, as GX arrested cells
Hudson, H. R., Rießland, M., & Orr, M. E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.006 · Cited by 26
Beidokhti, M. N., Villalba, N., Ma, Y., Reynolds, A., Villamil, J. H., & Yuan, S. Y. (2025) · GeroScience · doi:10.1007/s11357-025-01517-9 · Cited by 24
Quantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 23
Hernández‐Mercado, E., Prieto‐Chávez, J. L., Arriaga‐Pizano, L., Hernández-Gutiérrez, S., Mendlovic, F., Königsberg, M., & López‐Díazguerrero, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910215 · Cited by 19
The crosstalk between cellular reprogramming and senescence in aging and regeneration
Chiche, A., Chen, C., & Li, H. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111005 · Cited by 22
Cardiac Cell Senescence and Redox Signaling
Cesselli, D., Aleksova, A., Sponga, S., Cervellin, C., Loreto, C. D., Tell, G., & Beltrami, A. P. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00038 · Cited by 23
Sharma, R., & Padwad, Y. S. (2019) · Nutrition · doi:10.1016/j.nut.2019.01.020 · Cited by 21
Genotoxic Stress-Induced Senescence
Fan, D. N.-Y., & Schmitt, C. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_10 · Cited by 21
Does Inflammation Contribute to Cancer Incidence and Mortality during Aging? A Conceptual Review
Guerville, F., Bourdel‐Marchasson, I., Déchanet‐Merville, J., Pellegrin, I., Soubeyran, P., Appay, V., & Lemoine, M. (2022) · Cancers · doi:10.3390/cancers14071622 · Cited by 28
Roato, I., Baima, G., Orrico, C., Balma, A. M., Alotto, D., Romano, F., Ferracini, R., Aimetti, M., & Mussano, F. D. (2023) · Biomedicines · doi:10.3390/biomedicines11092535 · Cited by 22
“Senescent cells also express p16Ink4a which may contribute to cell growth arrest and stem cell exhaustion [15].”
BackgroundCong, X., Li, X., Xu, K., Yin, L., Liang, G., Sun, R., Pu, Y., & Zhang, J. (2024) · Environment International · doi:10.1016/j.envint.2024.108493 · Cited by 22
Huang, Z., Xu, P., Hess, D. C., & Zhang, Q. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00457-2 · Cited by 20
Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act
Lubberts, S., Meijer, C., Demaria, M., & Gietema, J. A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102963 · Cited by 19
“…cells alleviates a wide range of age-related symptoms, including cardiovascular and renal dysfunction, sarcopenia, osteoporosis, frailty, hypercholesterolemia and neurodegeneration (Baker et al., 2016; Roos et al., 2016; Baar et al., 2017; Xu et al., 2015a; Bussian et al., 2018; Xu et al., 2018).”
BackgroundParrondo's paradox reveals counterintuitive wins in biology and decision making in society
Wen, T., & Cheong, K. H. (2024) · Physics of Life Reviews · doi:10.1016/j.plrev.2024.08.002 · Cited by 22
Cellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
Booth, L. K., Redgrave, R. E., Tual‐Chalot, S., Spyridopoulos, I., Phillips, H. M., & Richardson, G. D. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_4 · Cited by 21
HCSGD: An integrated database of human cellular senescence genes
Dong, Q., Han, H., Liu, X., Wei, L., Zhang, W., Zhao, Z., Zhang, M. Q., & Wang, X. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.04.001 · Cited by 24
Senolytic effect of high intensity interval exercise on human skeletal muscle
Jean, W.-H., Hsieh, Y.-W., Lai, L.-F., Dewi, L., Liao, Y.-C., Ye, M., Yu, S.-H., Kao, C.-L., Huang, C.-Y., & Kuo, C.-H. (2023) · Aging · doi:10.18632/aging.204511 · Cited by 18
Song, S., Perez, J. V., Svitko, W., Ricketts, M. D., Dean, E., Schultz, D., Marmorstein, R., & Johnson, F. B. (2019) · Aging Cell · doi:10.1111/acel.13061 · Cited by 20
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Lipophilic Statins Eliminate Senescent Endothelial Cells by inducing Anoikis-Related Cell Death
Beláková, B., Wedige, N., Awad, E. M., Heß, S., Oszwald, A., Fellner, M., Khan, S. Y., Resch, U., Lipovac, M., Šmejkal, K., et al. (2023) · Cells · doi:10.3390/cells12242836 · Cited by 19
“First, since senescent cells are viewed as damaged cells that have successfully evolved resistance to apoptosis, and the search for senolytic compounds often involves substances that would allow the induction of apoptosis again [9,46,47].”
BackgroundFlow cytometric identification and cell-line establishment of macrophages in naked mole-rats
Wada, H., Shibata, Y., Abe, Y., Otsuka, R., Eguchi, N., Kawamura, Y., Oka, K., Baghdadi, M., Atsumi, T., Miura, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54442-1 · Cited by 23
From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease
Hayashide, L. D. S., Pessoa, B., Dias, G. R., Pontes, B., Pinto, R. S., & Diniz, L. P. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70361 · Cited by 21
“These experiments demonstrated that removal of senescent cells delayed both natural and premature aging in mice, providing proof of concept that targeting cellular senescence can extend healthspan and mitigate age-associated pathologies (Baker et al. 2011, 2016).”
Ling, M., Tang, C.-M., Yang, X., Yu, N., Song, Y., Ding, W., Sun, Y., Yan, R., Wang, S., Li, X., et al. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113566 · Cited by 21
Hernández‐González, F., Pietrocola, F., Cameli, P., Bargagli, E., Prieto‐González, S., Cruz, T., Mendoza, N., Rojas, M. M., Serrano, M., Agustí, A. G. N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147554 · Cited by 19
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage
Wang, Y., Eng, D. G., Pippin, J. W., Gharib, S. A., McClelland, A. D., Gross, K. W., & Shankland, S. J. (2018) · Aging · doi:10.18632/aging.101416 · Cited by 18
Wen, J., Bao, M., Tang, M., He, X., Yao, X., & Li, L. (2021) · Aging · doi:10.18632/aging.202907 · Cited by 21
p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice
Hill, R. J., Bona, N., Smink, J., Webb, H. K., Crisp, A., Garaycoechea, J. I., & Crossan, G. P. (2024) · Nature Communications · doi:10.1038/s41467-024-46844-1 · Cited by 25
Chen, M., Wu, G., Lu, Y., Sun, S., Zhao, Y., Pan, X., Chen, W., Xu, J., Qiu, H., He, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.002 · Cited by 19
Integrin-linked kinase: A new actor in the ageing process?
Olmos, G., López‐Ongil, S., & Ruiz‐Torres, M. P. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.026 · Cited by 18
Kim, J., Park, I., Shin, H. R., Rhee, J., Seo, J., Jo, Y., Yoo, K., Hann, S., Kang, J., Park, J., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12653 · Cited by 22
MYSM1 Suppresses Cellular Senescence and the Aging Process to Prolong Lifespan
Tian, M., Huang, Y., Song, Y., Li, W., Zhao, P., Liu, W., Wu, K., & Wu, J. (2020) · Advanced Science · doi:10.1002/advs.202001950 · Cited by 18
Bench to bedside: Current advances in regenerative medicine
Clarke, G., Harley, P., Hubber, E.-L., Manea, T., Manuelli, L., Read, E., & Watt, F. M. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.05.006 · Cited by 18
Demaria, M., Bertozzi, B., Veronese, N., Spelta, F., Cava, E., Tosti, V., Piccio, L. M., Early, D. S., & Fontana, L. (2023) · npj Aging · doi:10.1038/s41514-023-00100-w · Cited by 20
Herb-Derived Products: Natural Tools to Delay and Counteract Stem Cell Senescence
Abruzzo, P. M., Canaider, S., Pizzuti, V., Pampanella, L., Casadei, R., Facchin, F., & Ventura, C. (2020) · Stem Cells International · doi:10.1155/2020/8827038 · Cited by 21
Cardiac stem cell aging and heart failure
Cesselli, D., Aleksova, A., Mazzega, E., Caragnano, A., & Beltrami, A. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.013 · Cited by 21
Murray, K. O., Mahoney, S. A., Ludwig, K. R., Miyamoto-Ditmon, J., VanDongen, N. S., Banskota, N., Herman, A. B., Seals, D. R., Mankowski, R. T., Rossman, M. J., et al. (2025) · Aging Cell · doi:10.1111/acel.70114 · Cited by 25
“However, senescent cells accumulate in excess with aging and promote physiological dysfunction, including declines in skeletal muscle strength (Baker et al. 2016; Dungan et al. 2022a, 2022b; Englund et al. 2023; Xu et al. 2018; Zhang et al. 2022) and increases in frailty (Wang et al. 2024).”
Cellular Senescence in Arterial Diseases
Shimizu, I., & Minamino, T. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.1.79 · Cited by 21
Suo, J., Shao, R., Yang, R., Wang, J., Zhang, Z., Wang, D., Niu, N., Zheng, X., & Zou, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05856-3 · Cited by 21
An evaluation of aging measures: from biomarkers to clocks
Wang, Q., Hou, T., Wang, Q., He, J., Wang, L., Si, J., & Chen, S. (2022) · Biogerontology · doi:10.1007/s10522-022-09997-4 · Cited by 19
“In rapidly aging mouse models, the removal of p16-expressing cells alleviated the age-related features and extended the median lifespan (Baker et al. 2016).”
BackgroundThe potential role of senescence in limiting fibrosis caused by aging
Meng, X., Wang, H., Song, X., Clifton, A. C., & Xiao, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29313 · Cited by 19
Loss of p16: A Bouncer of the Immunological Surveillance?
Leon, K. E., Tangudu, N. K., Aird, K. M., & Buj, R. (2021) · Life · doi:10.3390/life11040309 · Cited by 23
Salminen, A. (2024) · Biogerontology · doi:10.1007/s10522-024-10114-w · Cited by 29
“Vol.: (0123456789) Interestingly, several mouse models of an accelerated aging have demonstrated that the removal of senescent cells from tissues actually attenuate pathological alterations taking place in aging tissues (Baker et al. 2016; Yi et al. 2023).”
BackgroundDysfunctional TRPM8 signalling in the vascular response to environmental cold in ageing
Thapa, D., Valente, J. D. S., Barrett, B., Smith, M. J., Argunhan, F., Lee, S. Y., Nikitochkina, S., Kodji, X., & Brain, S. D. (2021) · eLife · doi:10.7554/elife.70153 · Cited by 24
Venkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Kuang, Z., Ge, Y., Cao, L., Wang, X., Liu, K., Wang, J., Zhu, X., Wu, M., & Li, J. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01238-9 · Cited by 28
p16ink4a Positivity of Melanocytes in Non-Segmental Vitiligo
Lee, J. W., Kim, T. H., Park, T. J., & Kang, H. Y. (2020) · Diagnostics · doi:10.3390/diagnostics10110878 · Cited by 20
Molnár, A., Pásztor, D. T., & Merkely, B. P. (2022) · Cells · doi:10.3390/cells11213389 · Cited by 18
The induction of the fibroblast extracellular senescence metabolome is a dynamic process
James, E. N., Bennett, M. H., & Parkinson, E. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-29809-5 · Cited by 18
Senolytics and the compression of late-life mortality
Kowald, A., & Kirkwood, T. B. L. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111588 · Cited by 24
A brief history of modern aging research
Zainabadi, K. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.01.018 · Cited by 24
Tamanini, S., Comi, G. P., & Corti, S. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0888-0 · Cited by 18
Rapid Detection of Senescent Mesenchymal Stromal Cells by a Fluorescent Probe
Ang, J., Lee, Y., Raghothaman, D., Jayaraman, P., Teo, K. L., Khan, F. J., Reuveny, S., Chang, Y., Kang, N., & Oh, S. (2019) · Biotechnology Journal · doi:10.1002/biot.201800691 · Cited by 18
Knockout of Canopy 2 activates p16INK4a pathway to impair cardiac repair
Yin, W., Guo, J., Zhang, C., Alibhai, F. J., Li, S., Billia, F., Wu, J., Yau, T. M., Weisel, R. D., & Li, R. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.018 · Cited by 17
Guo, D., Shen, Y., Li, W., Li, Q., Zhao, Y., Pan, C., Chen, B., Zhong, Y., & Miao, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00320 · Cited by 19
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.